What are the key counseling points for a patient with essential thrombocytosis (ET) starting hydroxyurea therapy?

Counseling Points for Essential Thrombocytosis (Hydroxyurea Therapy)

Disease Understanding and Treatment Goals

Patients with essential thrombocytosis starting hydroxyurea must understand that the primary goal is preventing life-threatening blood clots by maintaining platelet counts below 400 × 10⁹/L, which reduces thrombotic events by approximately 80% compared to no treatment. 1, 2

• Hydroxyurea combined with low-dose aspirin (81-100 mg daily) is the gold standard first-line therapy for high-risk ET patients, proven superior to other combinations in reducing thrombosis, major bleeding, and progression to myelofibrosis 3
• The medication works by suppressing bone marrow production of platelets, typically achieving target platelet counts in 51% of patients within the first year 4
• Treatment is long-term and potentially lifelong, requiring consistent adherence to prevent thrombotic complications 5, 3

Dosing and Medication Administration

• Starting dose is typically 15-20 mg/kg/day (or 2-2.5 g/day for patients over 80 kg), with titration based on blood count response 5, 3, 6
• Take the medication at the same time daily for consistent blood levels 5
• Do not stop or adjust the dose without consulting your hematologist, even if you feel well 5

Critical Monitoring Requirements

Blood count monitoring is mandatory—expect weekly complete blood counts initially, then every 4-8 weeks once stabilized—as hydroxyurea can cause dangerous drops in all blood cell types. 5, 7

• Immediately report fever, unusual bleeding, bruising, persistent fatigue, or signs of infection (sore throat, mouth sores, cough) as these may indicate severe bone marrow suppression 7
• Target goals include platelet count <400 × 10⁹/L, white blood cell count <10 × 10⁹/L, and resolution of symptoms 5

Serious Side Effects Requiring Immediate Medical Attention

Bone Marrow Suppression (Most Common Serious Risk)

• Therapy must be stopped immediately if absolute neutrophil count falls below 1.0 × 10⁹/L, platelet count below 100 × 10⁹/L, or hemoglobin below 10 g/dL 8, 6, 7
• These thresholds represent mandatory discontinuation criteria, not just dose reduction 6

Skin and Vascular Complications

• Leg ulcers and painful skin lesions can develop at any dose and require immediate discontinuation 8, 5, 7
• Report any new skin rashes, mouth sores, or non-healing wounds 5, 7
• Cutaneous vasculitic toxicities are recognized complications requiring treatment cessation 7

Hemolytic Anemia

• Not all anemia from hydroxyurea is due to bone marrow suppression—some patients develop hemolytic anemia requiring blood transfusions 7, 9
• Your physician will monitor for this with specific blood tests if persistent anemia develops 7, 9

Pulmonary Toxicity

• Seek immediate medical attention for new fever, cough, shortness of breath, or other respiratory symptoms as these may indicate rare but serious lung toxicity 7

Cancer Risk and Long-Term Considerations

• Hydroxyurea carries a small but real risk of causing secondary leukemia and skin cancers with long-term use 7
• This risk is particularly concerning for patients under 40 years old, who should use hydroxyurea only when absolutely necessary 5, 6
• Regular skin examinations are recommended to detect skin cancers early 7
• The benefits of preventing thrombosis typically outweigh leukemia risk in high-risk patients, but this requires ongoing discussion 5, 7

Reproductive and Pregnancy Concerns

Hydroxyurea causes severe birth defects and is absolutely contraindicated in pregnancy—both women and men must use effective contraception during treatment and for a period after stopping. 7

• Women of childbearing potential must have a negative pregnancy test before starting therapy 7
• Notify your physician immediately if pregnancy occurs or is suspected 7
• If cytoreduction is needed during pregnancy, interferon-alpha is the only acceptable alternative 3
• Do not breastfeed while taking hydroxyurea 7
• Males should also use contraception as the drug may affect sperm and potentially harm a fetus 7

Infection and Vaccination Precautions

• Avoid live vaccines while on hydroxyurea as your suppressed immune system may cause severe infections from the vaccine 7
• Discuss all planned vaccinations with your hematologist before receiving them 7
• The risk of herpes zoster infection may be increased 8

Treatment Response and Resistance Criteria

Signs of Adequate Response

• Platelet count maintained below 400 × 10⁹/L consistently 5, 4
• Resolution of symptoms such as headaches, visual disturbances, or abnormal bleeding 5
• Achieving complete hematological response is associated with 65% reduction in arterial thrombosis risk in high-risk patients 4

Signs of Treatment Failure (Resistance)

If after 3 months on adequate doses (at least 2 g/day, or 2.5 g/day if you weigh >80 kg), your platelet count remains above 600 × 10⁹/L, this indicates hydroxyurea resistance requiring alternative therapy. 8, 5, 6

• Other resistance criteria include platelet count >400 × 10⁹/L with hemoglobin <10 g/dL at any dose 8
• Development of leg ulcers, severe mucocutaneous toxicity, or hydroxyurea-related fever at any dose 8, 5
• Second-line options include anagrelide or interferon-alpha 5, 3

Medication Interactions and Special Situations

• If you use a continuous glucose monitoring system for diabetes, notify your healthcare team as hydroxyurea may cause falsely elevated glucose readings 7
• If you previously received radiation therapy, you may experience reactivation of skin reactions in the radiated area 7
• Patients with HIV require special monitoring for pancreatitis, liver problems, and nerve damage 7

Cardiovascular Risk Factor Management

• Aggressively control all cardiovascular risk factors (hypertension, diabetes, cholesterol, smoking) as these compound your thrombosis risk beyond what hydroxyurea alone can prevent 5
• Continue low-dose aspirin as prescribed unless contraindicated by very high platelet counts (>1,500 × 10⁹/L) or bleeding complications 3

Common but Less Serious Side Effects

• Gastrointestinal symptoms (nausea, vomiting, diarrhea) may occur 5, 7
• Mild skin and nail changes are common 5
• Hair thinning may develop 5
• These typically do not require stopping the medication unless severe 5

When to Contact Your Hematologist Urgently

• Fever above 100.4°F (38°C) 7
• Unusual bleeding or bruising 7
• Severe fatigue or weakness 7
• New leg ulcers or non-healing wounds 8, 5
• Shortness of breath or persistent cough 7
• Signs of blood clots (leg swelling, chest pain, stroke symptoms) 1, 2
• Any new or worsening symptoms 7